
|Articles|February 1, 2017
- Pharmaceutical Executive-02-01-2017
- Volume 37
- Issue 2
Pharmaceutical Executive, February 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 9 years ago
Region in Reform? Access Pains and Gains in Latin Americaalmost 9 years ago
CMED: The ‘Curupira’ of Brazil’s Pharma Marketalmost 9 years ago
The Trouble with Pharma Partnerships ... And How to Fix Themalmost 9 years ago
Reducing the Risk of Noncompliancealmost 9 years ago
When You Need Experts, Use Themalmost 9 years ago
Pricing Pressures and Policy Changesabout 9 years ago
Not Your Typical Pharma Datelineabout 9 years ago
Market Access: Current and Future Statesabout 9 years ago
Market Access: A UK Perspectiveabout 9 years ago
Country Report: SingaporeNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Announces New $3.5 Billion Manufacturing Facility in Pennsylvania
2
ACIP Member Claims FDA Commissioner is Halting Decision to Remove Covid Vaccines from the Market: Report
3
FDA Announces New Domestic-Manufacturing-Focused Pilot Program
4
Pharmaceutical Executive Daily: FDA Reveals PreCheck Pilot Program
5




